Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

The True Post icon

Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.

Source: CNBC

Share This Article
The newsroom of The True Post.
Leave a Comment